Propranolol's Cardiovascular Effects in Akathisia Treatment

Mechanism and Clinical Significance

• The American College of Cardiology and Circulation guideline-directed therapy suggests that propranolol doses of 30-80 mg/day for akathisia can cause cardiovascular effects, including decreased systolic blood pressure and heart rate, due to its non-selective beta-adrenergic receptor blockade 1, 2

Patient Monitoring and Management

• The American Heart Association recommends that patients with pre-existing cardiovascular disease require careful monitoring and may need dose adjustments or alternative treatments when using propranolol for akathisia, as it can precipitate hypotension in patients with borderline cardiac output 4
• The European Heart Journal suggests that propranolol is contraindicated in patients with sinus bradycardia, greater than first-degree AV block, cardiogenic shock, or decompensated heart failure, and recommends baseline assessment and monitoring of heart rate, blood pressure, and ECG before initiating therapy 3, 5

Special Considerations

• The American College of Cardiology recommends that in patients with stable ischemic heart disease, propranolol can be beneficial but requires monitoring for excessive bradycardia or hypotension 1, 2
• The European Society of Cardiology suggests that patients with COPD or asthma should use propranolol with extreme caution or consider alternatives due to its non-selective beta-blockade, which can cause bronchoconstriction 4, 7